Publications by authors named "M Mehlig"

Claim this Profile
P
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects.
Puja Sapra, Patricia Kraft, Fabio Pastorino, Domenico Ribatti, Melissa Dumble, Mary Mehlig

Angiogenesis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma.
Puja Sapra, Patricia Kraft, Mary Mehlig, Jennifer Malaby, Hong Zhao

Haematologica· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.
Puja Sapra, Hong Zhao, Mary Mehlig, Jennifer Malaby, Patricia Kraft

Clin Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of G3139 using releasable PEG-linkers: impact on pharmacokinetic profile and anti-tumor efficacy.
Hong Zhao, Ping Peng, Clifford Longley, Yue Zhang, Virna Borowski, Mary Mehlig

J Control Release· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
Maoliang Wang, Amartya Basu, Thomas Palm, Jack Hua, Stephen Youngster, Mary Mehlig

Bioconjug Chem· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis